Novo CEO pressed by Senate to cut costs of weight problems, diabetes drugs CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would take into consideration new talks with insurers with regard to the record charges of Wegovy and copyright when they pledge to help keep the medicines on their formularies. https://label-the-figure-with-the83838.timeblog.net/66473337/facts-about-healthcare-news-revealed